Arrowhead Research Corporation (Nasdaq:ARWR) announced today that U.S. Patent No. 7,091,192, titled “Linear Cyclodextrin Copolymers,” has been issued to the California Institute of Technology. The patent is exclusively licensed to Arrowhead’s majority-owned subsidiary, Insert Therapeutics, a company commercializing delivery-enhanced therapeutics using a patented class of polymeric systems.
